Ethics roundtable: Using new, expensive drugs

Costly genetically engineered therapies, which threaten to cripple the health care industry economy and undermine the common good if applied indiscriminately, loom on the horizon. The spectrum of applicable candidates include moribund nursing home patients at the end of life. They will be fair game...

Descripción completa

Detalles Bibliográficos
Autores principales: Burrows, Richard, Crippen, David, Dellinger, R Phillip, Kelly, David F, Streat, Stephen, Whetstine, Leslie M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC153428/
https://www.ncbi.nlm.nih.gov/pubmed/12493067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC153428/
https://www.ncbi.nlm.nih.gov/pubmed/12493067

Ejemplares similares